- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07526584
Confronto degli effetti degli schemi di etichettatura fronte-pacchetto in Indonesia
Confronto degli effetti di due sistemi di etichettatura front-of-package tra i consumatori indonesiani
The goal of this study is to examine what type of front-of-package label (FOPL) would be most effective at discouraging consumption of products high in nutrients of concern in Indonesia. The main questions this experiment aims to answer are:
- Would nutrient warning labels be more effective at discouraging consumption of products high in nutrients of concern compared to the Nutri-Level label?
- Would nutrient warning labels improve consumers' ability to identify unhealthy products compared to the Nutri-Level label?
Additionally, this experiment also aims to determine how should nutrient warning labels be designed to most effectively discourage consumption of products high in nutrients of concern among Indonesian consumers.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Participants will complete an online randomized experiment programmed in Qualtrics. Following online consent, participants will be randomly assigned to one of two arms: 1. Nutrient Warning Label 2. Nutri-Level Label (color-coded summary nutritional label). Participants will view four different products (sweet tea, sausages, instant noodles, and yogurt) carrying their assigned label and will answer a series of questions about the products and the labels. All participants will then see nutrient warning labels with different designs in random order, and will select the label design they consider to best signal when products have high in nutrients of concern. Survey questions will also include standard demographic and health related variables.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
North Carolina
-
Chapel Hill, North Carolina, Stati Uniti, 27516
- Carolina Population Center
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- 18 years of age or older
- Lives in Indonesia
- Able to read and write in Indonesian
- Has purchased processed foods in the last month
Exclusion Criteria:
- Less than 18 years old
- Does not live in Indonesia
- Not able to read and write in Indonesian
- Has not purchased processed foods in the last month
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Nutrient Warning Label
Participants are assigned to view food products displaying nutrient warning labels indicating that the product is high in sugar, salt, and/or fat. |
Presentation of food products with one or more nutrient warning labels (black octagons) indicating that the product is high in sugar, salt, and/or fat. |
|
Sperimentale: Nutri-Level
Participants are assigned to view food products displaying a Nutri-Level summary nutrition label. |
Presentation of food products with a Nutri-Level summary nutrition label assigning a letter grade (A-D) based on sugar, salt, and/or fat content. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Correct identification of products high in nutrients of concern
Lasso di tempo: During exposure to intervention (i.e., study stimuli), assessed during one-time online 10-minute survey.
|
Correct identification of products as high in nutrients of concern will be measured categorically by survey. Response will be coded in a dichotomous 0-1 range, where 1 indicates that the participant correctly identified that the product was high in a nutrient of concern and 0 indicates that the participant did not correctly identify that the products was high in a nutrient of concern. |
During exposure to intervention (i.e., study stimuli), assessed during one-time online 10-minute survey.
|
|
Purchase intentions
Lasso di tempo: During exposure to intervention (i.e., study stimuli), assessed during one-time online 10-minute survey.
|
How likely participants would be to buy this product in the next week if it were available in a store will be measured by survey. Response options will be on a 5-point scale between "extremely unlikely" (coded as 1) and "extremely likely" (coded as 5), with higher scores representing higher intent to purchase the product. |
During exposure to intervention (i.e., study stimuli), assessed during one-time online 10-minute survey.
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Attention drawn by the labels
Lasso di tempo: During exposure to intervention (i.e., study stimuli), assessed during one-time online 10-minute survey.
|
How much attention the labels draw will be measured by survey. Response options will be on a 5-point scale between "not at all" (coded as 1) and "extremely" (coded as 5), with higher scores representing more attention drawn by the labels. |
During exposure to intervention (i.e., study stimuli), assessed during one-time online 10-minute survey.
|
|
Ease of understanding the labels
Lasso di tempo: During exposure to intervention (i.e., study stimuli), assessed during one-time online 10-minute survey.
|
How easy or difficult the information presented by the labels is to understand will be measured by survey. Response options will be on a 5-point scale between "very difficult" (coded as 1) and "very easy" (coded as 5), with higher scores representing higher ease of understanding the labels. |
During exposure to intervention (i.e., study stimuli), assessed during one-time online 10-minute survey.
|
|
Perceived message effectiveness
Lasso di tempo: During exposure to intervention (i.e., study stimuli), assessed during one-time online 10-minute survey.
|
Perceived message effectiveness will be measured by survey through a three-item scale. Items will inquire about how much participants perceive the labels to (1) discourage them from wanting to buy products with non-nutritive sweeteners for their child, (2) make them concerned about the health effects of their child consuming products with non-nutritive sweeteners, and (3) make buying products with non-nutritive sweeteners for their child seem unpleasant to them. Response options will be on a 5-point scale between "not at all" (coded as 1) and "very much" (coded as 5), with higher scores representing a higher perceived message effectiveness. Each participant's responses to each item will be combined to obtain their final score on the outcome. |
During exposure to intervention (i.e., study stimuli), assessed during one-time online 10-minute survey.
|
|
Perceived product healthfulness
Lasso di tempo: During exposure to intervention (i.e., study stimuli), assessed during one-time online 10-minute survey.
|
How good or bad for the participant's health would it be to consume this product frequently will be measured by survey. Response options will be on a 5-point scale between "very bad" (coded as 1) and "very good" (coded as 5), with higher scores representing higher perceived product healthfulness. |
During exposure to intervention (i.e., study stimuli), assessed during one-time online 10-minute survey.
|
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Support for the labels
Lasso di tempo: During exposure to intervention (i.e., study stimuli), assessed during one-time online 10-minute survey.
|
How much participants would oppose or support a law requiring the labels products with too much sugar, salt, and fat will be measured by survey. Response options will be on a 5-point scale between "strongly oppose" (coded as 1) and "Strongly support" (coded as 5), with higher scores representing higher support for the labels. |
During exposure to intervention (i.e., study stimuli), assessed during one-time online 10-minute survey.
|
|
Trust in the labels
Lasso di tempo: During exposure to intervention (i.e., study stimuli), assessed during one-time online 10-minute survey.
|
How much participants trust or distrust the information presented by the labels will be measured by survey. Response options will be on a 5-point scale between "distrust completely" (coded as 1) and "trust completely" (coded as 5), with higher scores representing more trust in the labels. |
During exposure to intervention (i.e., study stimuli), assessed during one-time online 10-minute survey.
|
|
Cultural acceptance of the labels
Lasso di tempo: During exposure to intervention (i.e., study stimuli), assessed during one-time online 10-minute survey.
|
How acceptable would the labels would be in Indonesian society will be measured by survey. Response options will be on a 5-point scale between "completely unacceptable" (coded as 1) and "completely acceptable" (coded as 5), with higher scores representing more cultural acceptance of the labels. |
During exposure to intervention (i.e., study stimuli), assessed during one-time online 10-minute survey.
|
|
Reactance to the labels
Lasso di tempo: During exposure to intervention (i.e., study stimuli), assessed during one-time online 10-minute survey.
|
Reactance to the labels will be measured by survey through a three-item scale. Items will inquire about how much participants agree or disagree that the labels (1) are trying to manipulate them, (2) are overblown, and (3) annoy them. Response options to each item will be on a 5-point scale between "strongly disagree" (coded as 1) and "strongly agree" (coded as 5), with higher scores representing a reactance to the labels. Each participant's responses to each item will be averaged to obtain their final score on the outcome on a scale between 1-5, where a higher score indicates higher reactance to the labels. |
During exposure to intervention (i.e., study stimuli), assessed during one-time online 10-minute survey.
|
Collaboratori e investigatori
Collaboratori
Investigatori
- Investigatore principale: Lindsey S Taillie, PhD, University of North Carolina, Chapel Hill
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 26-0181
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
The Study Protocol and Statistical Analysis Plan will be shared prior to data collection. After data collection and analysis, a de-identified version of individual participant data and the analytic code will be shared through the Open Science Framework (OSF).
Periodo di condivisione IPD
The Study Protocol and statistical analysis plan will be available by April 2026 (prior to data collection). A de-identified version of the data collected and analytic code used will become available after data collection and analysis and will remain available indefinitely.
Criteri di accesso alla condivisione IPD
Open access
Tipo di informazioni di supporto alla condivisione IPD
- STUDIO_PROTOCOLLO
- CODICE_ANALITICO
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .